123 related articles for article (PubMed ID: 26288222)
1. Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study.
Meid AD; Quinzler R; Freigofas J; Saum KU; Schöttker B; Holleczek B; Heider D; König HH; Brenner H; Haefeli WE
PLoS One; 2015; 10(8):e0136339. PubMed ID: 26288222
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life.
Meid AD; Quinzler R; Groll A; Wild B; Saum KU; Schöttker B; Heider D; König HH; Brenner H; Haefeli WE
Eur J Clin Pharmacol; 2016 Jul; 72(7):877-85. PubMed ID: 27023462
[TBL] [Abstract][Full Text] [Related]
3. Age-Dependent Impact of Medication Underuse and Strategies for Improvement.
Meid AD; Haefeli WE
Gerontology; 2016; 62(5):491-9. PubMed ID: 26844916
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and prescribing quality in older people.
Steinman MA; Landefeld CS; Rosenthal GE; Berthenthal D; Sen S; Kaboli PJ
J Am Geriatr Soc; 2006 Oct; 54(10):1516-23. PubMed ID: 17038068
[TBL] [Abstract][Full Text] [Related]
5. A national survey on aspirin patterns of use and persistence in community outpatients in Italy.
Filippi A; Bianchi C; Parazzini F; Cricelli C; Sessa E; Mazzaglia G
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):695-703. PubMed ID: 21450601
[TBL] [Abstract][Full Text] [Related]
6. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
[TBL] [Abstract][Full Text] [Related]
7. [Potentially inappropriate prescribing cardiovascular medications in the aged population: prospective study in a district hospital centre (France)].
Gentes É; Hertzog M; Vogel T; Lang PO
Presse Med; 2015 Feb; 44(2):e41-50. PubMed ID: 25535164
[TBL] [Abstract][Full Text] [Related]
8. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries.
Dehghan M; Mente A; Teo KK; Gao P; Sleight P; Dagenais G; Avezum A; Probstfield JL; Dans T; Yusuf S;
Circulation; 2012 Dec; 126(23):2705-12. PubMed ID: 23212996
[TBL] [Abstract][Full Text] [Related]
9. [Definition and issue of medications underuse in frail elderly patients].
Piau A; Hein C; Nourhashemi F; Sebbagh M; Legrain S
Geriatr Psychol Neuropsychiatr Vieil; 2012 Jun; 10(2):129-35. PubMed ID: 22713840
[TBL] [Abstract][Full Text] [Related]
10. IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care.
Selak V; Elley CR; Crengle S; Harwood M; Doughty R; Arroll B; Bryant L; Rafter N; Hoorn SV; Wadham A; Wells S; Milne R; Jackson R; Bramley D; Rodgers A
Contemp Clin Trials; 2011 Nov; 32(6):909-15. PubMed ID: 21777702
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment and cost of cardiovascular disease in Australia.
Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
[TBL] [Abstract][Full Text] [Related]
12. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
[TBL] [Abstract][Full Text] [Related]
13. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
14. A polypill strategy to improve adherence: results from the FOCUS project.
Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
[TBL] [Abstract][Full Text] [Related]
15. Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication.
Hromadkova L; Heerdink ER; Philbert D; Bouvy ML
Int J Clin Pract; 2015 Mar; 69(3):328-35. PubMed ID: 25311143
[TBL] [Abstract][Full Text] [Related]
16. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
Czernichow S; Knol MJ; Fezeu L; Grobbee DE
Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
[TBL] [Abstract][Full Text] [Related]
17. The use of a frailty index to predict adverse health outcomes (falls, fractures, hospitalization, medication use, comorbid conditions) in people with intellectual disabilities.
Schoufour JD; Echteld MA; Bastiaanse LP; Evenhuis HM
Res Dev Disabil; 2015 Mar; 38():39-47. PubMed ID: 25576875
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy.
Gazmararian JA; Kripalani S; Miller MJ; Echt KV; Ren J; Rask K
J Gen Intern Med; 2006 Dec; 21(12):1215-21. PubMed ID: 17105519
[TBL] [Abstract][Full Text] [Related]
19. Cost-related medication underuse: prevalence among hospitalized managed care patients.
Choudhry NK; Saya UY; Shrank WH; Greenberg JO; Melia C; Bilodeau A; Kadehjian EK; Dolan ML; Dudley JC; Kachalia A
J Hosp Med; 2012 Feb; 7(2):104-9. PubMed ID: 21972200
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting.
Abolhassani N; Marques-Vidal P
J Clin Epidemiol; 2018 Sep; 101():1-4. PubMed ID: 29777797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
